ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Chugai Pharmaceutical Co., Ltd. ?
1
Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 23.71%
- Healthy long term growth as Net Sales has grown by an annual rate of 11.43% and Operating profit at 19.46%
- Company has very low debt and has enough cash to service the debt requirements
2
The company has declared Positive results for the last 4 consecutive quarters
- ROCE(HY) Highest at 22.1%
- NET PROFIT(Q) Highest at JPY 128,410 MM
- DIVIDEND PAYOUT RATIO(Y) Highest at 188.4%
3
With ROE of 21.74%, it has a attractive valuation with a 6.45 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 19.60%, its profits have risen by 24.1% ; the PEG ratio of the company is 1.2
- At the current price, the company has a high dividend yield of 0
4
Majority shareholders : Non Institution
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Chugai Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Chugai Pharmaceutical Co., Ltd. for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Chugai Pharmaceutical Co., Ltd.
19.6%
274.45
46.42%
Japan Nikkei 225
36.73%
1.30
28.24%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
11.43%
EBIT Growth (5y)
19.46%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.50
Sales to Capital Employed (avg)
0.67
Tax Ratio
29.16%
Dividend Payout Ratio
41.63%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
52.96%
ROE (avg)
23.71%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
30
Industry P/E
Price to Book Value
6.45
EV to EBIT
19.52
EV to EBITDA
19.42
EV to Capital Employed
11.81
EV to Sales
9.30
PEG Ratio
1.23
Dividend Yield
0.01%
ROCE (Latest)
60.50%
ROE (Latest)
21.74%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend12What is working for the Company
ROCE(HY)
Highest at 22.1%
NET PROFIT(Q)
Highest at JPY 128,410 MM
DIVIDEND PAYOUT RATIO(Y)
Highest at 188.4%
RAW MATERIAL COST(Y)
Fallen by -8.76% (YoY
CASH AND EQV(HY)
Highest at JPY 1,862,143 MM
DIVIDEND PER SHARE(HY)
Highest at JPY 3.23
NET SALES(Q)
Highest at JPY 346,301 MM
EPS(Q)
Highest at JPY 78.02
-12What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at JPY 389,451 MM
INTEREST COVERAGE RATIO(Q)
Lowest at 18,535.12
DEBT-EQUITY RATIO
(HY)
Highest at 0 %
INTEREST(Q)
Highest at JPY 914 MM
Here's what is working for Chugai Pharmaceutical Co., Ltd.
Net Profit
Highest at JPY 128,410 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Net Profit trend is very positive
Net Profit (JPY MM)
Net Sales
Highest at JPY 346,301 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (JPY MM)
Net Sales
At JPY 346,301 MM has Grown at 14.13%
over average net sales of the previous four periods of JPY 303,428.25 MMMOJO Watch
Near term sales trend is positive
Net Sales (JPY MM)
EPS
Highest at JPY 78.02
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (JPY)
Cash and Eqv
Highest at JPY 1,862,143 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Dividend per share
Highest at JPY 3.23
in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (JPY)
Dividend Payout Ratio
Highest at 188.4%
in the last five yearsMOJO Watch
Company is distributing higher proportion of profits generated as dividend
DPR (%)
Raw Material Cost
Fallen by -8.76% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Chugai Pharmaceutical Co., Ltd.
Interest
At JPY 914 MM has Grown at 1,475.86%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Interest Coverage Ratio
Lowest at 18,535.12
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Operating Cash Flow
Lowest at JPY 389,451 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (JPY MM)
Interest
Highest at JPY 914 MM
in the last five periods and Increased by 1,475.86% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Debt-Equity Ratio
Highest at 0 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
